Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

KRSNAA DIAGNOSTICS LTD.

NSE : KRSNAABSE : 543328ISIN CODE : INE08LI01020Industry : Hospital & Healthcare ServicesHouse : Private

BSE706.250.9 (+0.13 %)

PREV CLOSE ( ) 705.35

OPEN PRICE ( ) 686.75

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3666

TODAY'S LOW / HIGH ( )686.75 714.65

52 WK LOW / HIGH ( )527.55 1041.8

NSE705.55-0.85 (-0.12 %)

PREV CLOSE( ) 706.40

OPEN PRICE ( ) 689.95

BID PRICE (QTY) 705.55 (1104)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 60100

TODAY'S LOW / HIGH( ) 684.10 715.00

52 WK LOW / HIGH ( )528.05 1044

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-12 2010

Management Info

Rajendra Mutha - Chairman Pallavi Bhatevara - Managing Director

Registered Office

Address S. No. 243, A- Hissa No. 6,Cts No. 4519, 4519/1, Near Chinchwad Station,Chinchwad, Taluka – Haveli,
Pune,
Maharashtra-411019

Phone 020-27402400

Email info@krsnaa.in

Website www.krsnaadiagnostics.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

22Mar Krsnaa Diagnostics informs about analy
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Req..

12Mar Krsnaa Diagnostics informs about press
Krsnaa Diagnostics has informed that it enclosed copies of notice given..

11Mar Krsnaa Diagnostics informs about notic
Krsnaa Diagnostics has informed that it enclosed the Notice of Postal Ba..

20Feb Krsnaa Diagnostics informs about earni
Pursuant to the Regulation 30 and 46 read with clause 15 of Para A of Pa..

14Feb Krsnaa Diagnostics informs about press
Krsnaa Diagnostics has informed that it enclosed copies of the newspaper..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	216	585.61
Gross Profit	283.66	719.45
Operating Profit	571.83	1629.58
Net Sales	1651.57	5900.19

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 4000.85 (1.05%)	M.Cap ( in Cr)1880.40
Thyrocare Tech. (BSE) 939.65 (3.53%)	M.Cap ( in Cr)4979.53
Max Healthcare Inst (BSE) 1126.95 (1.50%)	M.Cap ( in Cr)109555.55
Metropolis Health. (BSE) 1667.15 (0.39%)	M.Cap ( in Cr)8549.64
RainbowChildrenS Med (BSE) 1346.45 (0.47%)	M.Cap ( in Cr)13673.43

Shareholding Pattern

	NON-INSTITUTION	54.94%
	PROMOTERS	27.24%
	MUTUAL FUNDS/UTI	9.36%
	FI/BANKS/INSURANCE	2.95%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata Small Cap Fund...	2.14
Kotak Healthcare Fu...	1.91
Bandhan Small Cap F...	0.35
Motilal Oswal BSE H...	0.11
Bandhan BSE Healthc...	0.11

Risk Disclosures on Derivatives

Smart Quotes

KRSNAA DIAGNOSTICS LTD.